Johnson & Johnson (JNJ) Tops Q3 EPS by 3c; Boosts FY11 Outlook
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $270.24 +1.07%
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $1.24, $0.03 better than the analyst estimate of $1.21. Revenue for the quarter came in at $16 billion versus the consensus estimate of $16.02 billion.
Johnson & Johnson sees FY2011 EPS of $4.95-$5.00, versus the consensus of $4.96. The company had previously guided to $4.90-$5.
Johnson & Johnson sees FY2011 EPS of $4.95-$5.00, versus the consensus of $4.96. The company had previously guided to $4.90-$5.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Navios Maritime Partners (NMM) Tops Q2 EPS by 34c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
